Select potential candidates with advanced prostate cancer for treatment with GnRH antagonists
|
|
|
|
|
|
Elucidate the differences between GnRH agonists and antagonists in terms of mechanism and clinical effect
|
|
|
|
|
|
Outline cardiovascular risks or benefits inherent in currently available GnRH agonists and antagonists as evidenced by clinical trials and other analyses in medical literature
|
|
|
|
|
|
Implement a shared decision-making approach and other techniques that will enhance adherence with oral anti-cancer medications
|
|
|
|
|
|